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This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).The subcellular position of a protein is a key determinant of its function. Mounting evidence indi-
cates that RNA localization, where specific mRNAs are transported subcellularly and subsequently
translated in response to localized signals, is an evolutionarily conserved mechanism to control
protein localization. On-site synthesis confers novel signaling properties to a protein and helps
to maintain local proteome homeostasis. Local translation plays particularly important roles in dis-
tal neuronal compartments, and dysregulated RNA localization and translation cause defects in
neuronal wiring and survival. Here, we discuss key findings in this area and possible implications
of this adaptable and swift mechanism for spatial control of gene function.Introduction
Many cellular proteins become localized to specific subcellular
locations. Spatial localization enables functional compartmen-
talization and is important for many aspects of cell signaling
and behavior. The most common mechanism for protein local-
ization involves direct targeting of the protein itself via specific
sequences such as the nuclear or mitochondrial localization
sequences (Imai and Nakai, 2010). However, a large-scale
in situ hybridization study inDrosophila embryogenesis revealed,
surprisingly, that 71% of mRNAs of the genes examined (20% of
total genes) localize to distinct subcellular compartments where,
in many cases, they colocalize with the proteins they encode
(Le´cuyer et al., 2007). This remarkable finding hints at the preva-
lence of an alternative mechanism for protein localization:
subcellular targeting of the mRNA encoding a protein and its
subsequent on-site translation. This RNA-based mechanism,
the focus of the current review, involves the coordination of mul-
tiple complex processes, including mRNA transport, targeting,
and translation, and enables remarkably precise stimulus-driven
control over protein position, abundance, and, to some extent,
function.
Subcellular RNA localization is highly prevalent in eukaryotes,
ranging from yeast (Gonsalvez et al., 2005) to highly specialized
cells such as neurons (Bramham and Wells, 2007; Jung et al.,
2012; Sutton and Schuman, 2006) and oligodendrocytes (Hoek
et al., 1998), and it is also found in bacteria (Keiler, 2011). Neu-
rons serve as an excellent model to understand RNA localization
as they are highly polarized: the distal tip of the neuronal axon is
remote from its cell body, sometimes a meter away, and there-
fore can be easily isolated (Campenot and Eng, 2000; Taylor26 Cell 157, March 27, 2014 ª2014 The Authorset al., 2009; Zivraj et al., 2010). Comparative subcellular tran-
scriptome analyses in neuronal processes have revealed that
distinct sets of mRNAs are targeted to different compartments
(Andreassi et al., 2010; Cajigas et al., 2012; Gumy et al., 2011;
Minis et al., 2014; Taylor et al., 2009; Zivraj et al., 2010). This
novel layer of intracellular patterning, originally thought to be ex-
clusive to highly specialized cells where it was first discovered
(Lasko, 2012), may occur widely in many cell types, as sug-
gested by the localization of subsets of mRNAs to cell protru-
sions in migrating fibroblasts (Lawrence and Singer, 1986; Mili
et al., 2008) (Figure 1).
RNA localization may be an evolutionarily conserved mecha-
nism that decentralizes genomic information and delegates its
control to subcellular compartments (Holt and Schuman,
2013). The genetic information encoded in the nucleus provides
the supply of mRNAs by transcription fromwhich specific sets of
mRNAs are chosen for subcellular localization. Chosen mRNAs
are targeted to multiple locations while their translation is re-
pressed during their transit (Erickson and Lykke-Andersen,
2011; Krichevsky and Kosik, 2001). The composition of trans-
ported mRNAs is regulated by both cell-intrinsic (Gumy et al.,
2011; Taylor et al., 2009; Zivraj et al., 2010) and -extrinsic signals
(Dictenberg et al., 2008; Mingle et al., 2005; Willis et al., 2007).
Thus, mRNAs are much more than simple ‘‘messengers’’ that
deliver the genetic information from DNA to the protein synthetic
apparatus, inasmuch as subcellularly targeted collections of
mRNAs can function as a genomic outpost. There, functionally
related mRNAs can be synchronously translated according to
biological needs, providing an efficient means for coordinate
control of gene expression (Keene and Tenenbaum, 2002),
Figure 1. Subcellular RNA Localization in Diverse Cell Types
(A) b-actinmRNA localizes to the periphery of migrating fibroblasts (Lawrence
and Singer, 1986).
(B) b-actinmRNA (magenta, in situ hybridization) localizes to the axonal growth
cone of a retinal ganglion cell neuron from a cultured Xenopus laevis eye pri-
mordium and partially colocalizes with the dynamic microtubule cytoskeleton
(green, anti-tyrosinated tubulin). Superresolution image acquired using a
DeltaVision OMX 3D-Structured-Illumination Microscope (Applied Precision),
with a 1003 1.4 NA oil objective. Extended focus image from deconvolved Z
stack images acquired at 0.125 mm step size B. Lu and C.E.H., unpublished).
Scale bar, 5 mm.comparable to the efficient bacterial operon system (Jacob et al.,
1960). Moreover, it is becoming increasingly clear that dysfunc-
tional RNA localization and translation represent one of most
common molecular pathologies of neurodevelopmental and
neurodegenerative diseases (Kelleher and Bear, 2008; Jung
et al., 2012; Liu-Yesucevitz et al., 2011; Ramaswami et al.,
2013; Wang et al., 2007).
In this review, we present localized translation as a distinct
mode of gene expression control that positions gene func-
tion with extreme spatiotemporal precision, efficiency, and
flexibility. We assess current knowledge of how distinct sub-
sets of mRNAs might be targeted to subcellular locations
where they await a signal to proceed synthesizing proteins
and relate how these RNA-based mechanisms might be linked
to general biological themes of Location Matters and Decoding
the Brain, which are covered elsewhere in this special reviews
issue.
Biological Function of Local Translation
Synthesizing a protein where and when it is needed provides
several advantages over transporting a pre-existing protein
from one place in the cell to another. Local synthesis confers
ultimate precision in protein localization, as a protein is present
only where it is needed and not anywhere else. On-site synthesis
instantly satisfies the biological demand for a protein without any
delay in its transport. Additionally, removing the reliance on a
protein-encoded transport signal means that the same protein
can be targeted to diverse subcellular compartments without
risking changing its structure or compromising its function. In
this latter case, the localization information can be encoded in
the mRNA untranslated region (UTR) rather than in the protein-
coding region. Finally, many copies of proteins can, in theory,be made from one mRNA molecule by multiple rounds of trans-
lation conferring an economical advantage.
Newly made proteins can play at least two roles. First, they
harbor unique information distinct from pre-existing ones, and
thus can be used to deliver an additional layer of signaling infor-
mation (Holt and Bullock, 2009). An alternative, but not mutually
exclusive role of newly made proteins is to replenish damaged,
degraded, or inactivated proteins to maintain local proteome
homeostasis.
Properties Unique to Newly Made Proteins Provide
Signaling Information
Location. The location of the birth of a protein encodes important
signaling information. The growth cone, the tip of a growing
axon, is thought to be nature’s most sensitive sensor of chemical
gradients as it can detect a concentration difference as little as
0.1% (Rosoff et al., 2004). When challenged with a gradient of
an attractive guidance cue, netrin-1 or brain-derived neurotro-
phic factor (BDNF), asymmetric translation of b-actin mRNA
occurs within the growth cone on the side nearest the source
of the gradient (Leung et al., 2006). This precise spatial regulation
of mRNA translation (growth cones are around 5 mm across) pre-
cedes and is required for the growth cone’s ability to turn toward
the source of the guidance cue (Leung et al., 2006; Yao et al.,
2006). In neuronal dendrites, on an even smaller scale, synaptic
activation induces transcript-specific translation only at the
stimulated synapses (Wang et al., 2009), allowing context-
dependent, spatially restricted changes in synaptic structure
and function.
There is evidence that transcription factors—such as CREB
(cyclic AMP-responsive element-binding protein) (Cox et al.,
2008), STAT3 (signal transducer and activator of transcrip-
tion 3) (Ben-Yaakov et al., 2012), and SMADs (homologs of
C. elegans small body size and Drosophila mothers against
decapentaplegic) (Ji and Jaffrey, 2012)—synthesized in distal
axons interact with the local signaling milieu immediately after
their synthesis, and carry this unique birth-place information to
the nucleus where it modulates their gene regulatory function.
Another intriguing case, although it remains to be corrobo-
rated, is the recent report of nuclear translation. Peptides en-
coded in the intron are generated by an unknown mode of
translation before pre-mRNA splicing and subsequent mRNA
nuclear export. The peptides are presented to the major histo-
compatibility complex (MHC) I pathway in cells expressing all
possible splice variants during T-cell-negative selection, thus
preventing autoimmune reactions (Apcher et al., 2013).
Time. The time of the birth of a protein can also encode signal-
ing information. Many proteins are subject to posttranslational
modifications as they execute their functions or even as they
age. Newly synthesized proteins thus are distinct from their ex-
istent counterparts in several important aspects. For example,
little or no posttranslational modification of a ‘‘new’’ b-actin
molecule provides information distinct from that of ‘‘old’’ ones
that have been posttranslationally modified by glutathionylation
(Wang et al., 2001) or arginylation (Karakozova et al., 2006). A
highly localized, sudden rise in nascent b-actin molecules, which
are likely to have a faster rate of polymerization than pre-existing
b-actins, may link the site of local protein synthesis and actin
nucleation (Condeelis and Singer, 2005).Cell 157, March 27, 2014 ª2014 The Authors 27
Local Proteome Homeostasis
In addition to generating highly localized signaling information,
localized mRNA translation is used to maintain local proteome
homeostasis (Alvarez et al., 2000). The mRNA encoding the ac-
tivated leukocyte cell adhesion molecule (ALCAM) localizes to
the neuronal axon. There, its translation is regulated by the cis-
element residing in its 30-UTR (Thelen et al., 2012). ALCAM me-
diates homophilic adhesion of axons from the same neuronal
subtype and is required for the formation of axon bundles.
Excess ALCAM leads to axon bundle aggregation and
prevents axonal growth, whereas too little ALCAM leads to de-
fasciculation. Intriguingly, introduction of exogenous full-length
ALCAMmRNA does not result in overexpression of ALCAM pro-
tein in axons, whereas the ALCAM mRNA lacking the 30-UTR
does, indicating that a mechanism exists to maintain the right
amount of ALCAM proteins on the axonal surface by local
translation.
This process has parallels with the resensitization of neuronal
axons to extrinsic cues. Neuronal axons navigating toward a
gradient of an attractive guidance cue must maintain the ability
to respond to the pre-encountered cue. The initial encounter
with an extrinsic cue leads to endocytosis of the activated recep-
tors, and local translation is required to compensate for the loss
of receptors from the axonal surface and to regain the ability to
respond to the same cue, a process known as adaptation (Piper
et al., 2005).
Similarly, localized translation coupled to nonsense-mediated
decay, a process that degrades mRNAs containing a premature
termination codon (PTC) preceding an exon junction complex
(EJC) and that is activated after the first round of translation,
maintains the right amount of Robo3.2 receptor in neuronal
axons to position commissural neuronal axons in the appropriate
place (Colak et al., 2013). Neuronal axons can synthesize locally
a significant amount of diverse proteins (10% synthesis per unit
volume compared to the cell body cytoplasm) (Lee and Hollen-
beck, 2003), suggesting that localized translation may provide
a quality control mechanism that ensures the optimal amount
of a protein is expressed in subcellular compartments.
Molecular Control of Translation
As described above, positioning the relevant mRNAs at the ap-
propriate place within a cell enables an accelerated response
to signaling inputs. With mRNAs stockpiled at distinct locations,
there is little time spent moving proteins through large regions of
cytoplasm. Translational activation of selected mRNAs at sites
within cells draws on established control mechanisms.
Translational control provides a powerful means to induce
rapid changes in protein amounts and, indeed, the abundance
of a protein in mammalian cells can be best predicted by the
rate of mRNA translation rather than by mRNA abundance
(Schwanha¨usser et al., 2011). Translation is controlled via a large
number of mechanisms (reviewed in Sonenberg and Hinne-
busch, 2009), including changes in the amounts and activities
of translation components: ribosomes, translation factors and
tRNAs. The best understood regulatory step is the phosphoryla-
tion of translation factors and their regulators, particularly that
of key eukaryotic translation initiation factors (eIFs). All eukary-
otic nuclear-transcribed mRNAs possess a 50-end cap structure.28 Cell 157, March 27, 2014 ª2014 The AuthorsTwomacromolecular complexes that function in cap-dependent
translation initiation, the eIF4F and the 43S preinitiation complex,
are the major targets of the translational regulation (Figure 2A).
Regulation via eIF4F, the Cap-Binding Complex
eIF4F is a heteromeric complex (Edery et al., 1983; Grifo et al.,
1983) that binds the cap structure and is composed of eIF4A
(RNA helicase), eIF4E (cap-binding protein) (Sonenberg et al.,
1979) and eIF4G (scaffolding protein) that binds both eIF4E
and eIF4A (Figure 2A). After binding to the cap, eIF4F unwinds
the mRNA 50-proximal secondary structure to facilitate the bind-
ing of the 43S preinitiation complex (see below).
eIF4F Formation Is Regulated by the Phosphorylation Status of
4E-BPs. Because eIF4E generally exhibits the lowest expression
level of all eIFs, the cap-recognition step by eIF4E is rate limiting
for translation and a major target for regulation (Gingras et al.,
1999). The best characterized mechanism that controls the in-
corporation of eIF4E into the cap-binding complex is that ex-
erted by members of the eIF4E-binding protein (4E-BP) family:
4E-BP1, 4E-BP2, and 4E-BP3 (Pause et al., 1994). 4E-BPs and
eIF4G share a common eIF4E-binding motif, through which
they compete for the binding to eIF4E (Figure 2A). Hypophos-
phorylated 4E-BPs bind eIF4E preventing it from associating
with eIF4G to form the eIF4F complex (Gingras et al., 1999).
mTORC1 Phosphorylates 4E-BPs. Phosphorylation of 4E-BPs
releases eIF4E to promote the formation of the eIF4F complex
and is, therefore, one of the rate-limiting steps in cap-dependent
translation (Gingras et al., 1999). 4E-BPs’ phosphorylation is
mainly controlled by the target of rapamycin (TOR), an evolutio-
narily conserved serine-threonine protein kinase of the phospha-
tidylinositol 3-kinase (PI3K)-related kinase family (Laplante and
Sabatini, 2012) (Figure 2B). TOR acts as a major sensor that in-
tegrates extracellular inputs, such as insulin, growth factors,
and nutrients, and intracellular levels of oxygen, energy levels,
and amino acids to effect outputs including cell growth, prolifer-
ation and autophagy (Hay and Sonenberg, 2004). Tor genes
were first discovered in yeast following a forward genetic screen
for mutations that confer resistance to the antifungal agent rapa-
mycin (Heitman et al., 1991), and subsequently its homologs
were identified in mammals (mammalian/mechanistic target of
rapamycin; mTOR) (Brown et al., 1994). mTOR is the catalytic
subunit of two distinct multiprotein complexes, mTORC1 and
mTORC2.
mTORC1 directly phosphorylates 4E-BPs (Brunn et al., 1997).
Upon phosphorylation by mTORC1, 4E-BPs dissociate from
eIF4E allowing it to form the eIF4F complex and to stimulate
translation. mTORC1 also phosphorylates S6 kinase (S6K) 1
and 2, which in turn phosphorylate regulators of translation initia-
tion such as S6, eIF4B, and PDCD4 (programmed cell death 4)
and to control their activities (Laplante and Sabatini, 2012).
mTORC1may also promote translation elongation by phosphor-
ylating eEF2K (eukaryotic elongation factor 2 kinase) that phos-
phorylates eEF2 (eukaryotic elongation factor 2) (Figure 2B)
(Laplante and Sabatini, 2012).
mTORC1 Pathway. The activity of mTORC1 is controlled by
the small GTPase Rheb (Ras homology enriched in brain), which
is negatively regulated by its GTPase activating proteins tuber-
ous sclerosis complex (TSC) 1 and 2. TSCs are inactive when
phosphorylated, and kinases that phosphorylate TSCs,
Figure 2. Translational Control in Mammals
(A) Cap-dependent translation (top). Translation in mammals is mainly regulated at the initiation step. The cap-binding eIF4F complex, downstream of mTORC1,
and the 43S preinitiation complex are the major targets of translational control.
(B) Regulation of cap-dependent translation (bottom). mTORC1 links cell-intrinsic and -extrinsic signals to translation initiation by phosphorylating S6Ks and 4E-
BPs. eIF2a phosphorylation represses translation. Excessively high or low translation activities are associated with neurodevelopmental and neurodegenerative
diseases, respectively (see text for more details).
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including Akt (also known as protein kinase B), ribosomal S6 kin-
ase (RSK) 1, and mitogen-activated protein kinase (MAPK)/ex-
tracellular signal-regulated kinase (ERK) (Laplante and Sabatini,
2012), are thus positive regulators of cap-dependent translation.
Phosphatase and tensin homolog (PTEN) dephosphorylates
phosphatidylinositol (3,4,5)-trisphosphate (PIP3) to form phos-
phatidylinositol (4,5)-bisphosphate (PIP2), and thus is a negative
regulator of mTORC1 (Figure 2B) (Hay and Sonenberg, 2004).
MAPK/ERK phosphorylates, in addition to TSC1/2, MAP kin-
ase-interacting kinase (Mnk) 1 and 2. Phosphorylated Mnks
then bind to eIF4G and phosphorylate eIF4E, promoting cap-de-
pendent translation (Buxade et al., 2008) (Figure 2A).
Localized mTORC1 Activation Leads to Localized Translation.
The activation of cell-surface receptors, such as those for neuro-
transmitters, hormones, neurotrophic factors, and extracellular
matrix components, links extrinsic signals to localized transla-
tion. For example, the synaptic activation of TrkB, a receptor
for brain-derived neurotrophic factor (BDNF), leads to phosphor-
ylation of TSCs in the dendritic spine and thus the localized
activation of cap-dependent translation (Takei et al., 2004).
mTORC1-dependent local protein synthesis in the dendritic
spine is required for the input-specific strengthening of synaptic
activity and the establishment of the late phase of long-term
potentiation (LTP), a cellular substrate of learning and memory
(Tang et al., 2002). Thus, coupling of cell-surface receptors to
mTORC1 transduces extrinsic cues into localized protein syn-
thesis (Graber et al., 2013; Hoeffer and Klann, 2010).
Control of 43S Ribosomal Preinitiation Complex
Formation
eIF2 (composed of a, b and g subunits) is a GTPase that forms a
ternary complex with guanosine-50-triphosphate (GTP) and the
initiator Met-tRNAi
Met. The ternary complex, together with other
eIFs, binds the 40S ribosomal subunit to form the 43S preinitia-
tion complex (Hinnebusch and Lorsch, 2012). The cap-binding
complex eIF4F recruits the 43S preinitiation complex and forms
the 48S initiation complex, which traverses the 50-UTR in the 50 to
30 direction until it encounters the initiation codon. There, eIF2
hydrolyzes GTP to guanosine diphosphate (GDP) and inorganic
phosphate, followed by the 60S subunit recruitment resulting
in the formation of the 80S ribosomal complex and the release
of eIFs (Figure 2A).
Selective Control of Translation by eIF2a. To sustain cap-
dependent translation, GTP-bound eIF2 must be replenished,
and this is done by eIF2B, the guanine nucleotide exchange fac-
tor (GEF) for eIF2. Phosphorylation of the a subunit of eIF2
(eIF2a) converts it into a dominant-negative inhibitor of eIF2B
and therefore decreases general translation (Mohammad-Qure-
shi et al., 2008). In higher eukaryotes, the phosphorylation of
eIF2a is controlled by four protein kinases: the double-stranded
(ds) RNA-activated protein kinase (PKR), which is activated by
dsRNA; the hemin-regulated inhibitor kinase (HRI), which is acti-
vated by heme deficiency; the pancreatic eIF2a or PKR-endo-
plasmic reticulum (ER)-related kinase (PEK/PERK), which is
activated by misfolded proteins in the ER; and the general con-
trol nonderepressible-2 (GCN2), which is activated by amino
acid deprivation and UV irradiation (Figure 2B). These kinases,
activated in response to virus infection, iron deficiency, protein
aggregation and nutritional deprivation, thus shut down protein30 Cell 157, March 27, 2014 ª2014 The Authorssynthetic machinery in response to various forms of cellular
stress. Paradoxically, the translation of a small subset ofmRNAs,
which contain upstream open reading frames (uORFs) in their
50UTRs, is stimulated when eIF2a is phosphorylated (Hinne-
busch, 1984). Such mRNAs include Atf4 mRNA (Costa-Mattioli
et al., 2005; Harding et al., 2000), whose localized translation in
dendritic spines may inhibit long-term potentiation and memory
formation (Costa-Mattioli et al., 2007).
Cap-Independent Translation
Eukaryotic mRNAs can also be translated by cap-independent
mechanisms, and one way is through an internal ribosome entry
site (IRES) of anmRNA. IRESswere first identified and character-
ized in picornavirus RNAs, which do not possess a 50-cap struc-
ture (Hellen and Sarnow, 2001). Although several dendritically
localized mRNAs contain IRES elements, how important and ex-
tensive IRES-mediated translation in vertebrates remains to be
determined (Thompson, 2012).
Repeat associated non-AUG (RAN) translation is another
mode of noncanonical translation, which initiates at trinucleotide
repeat tracts in the absence of an initiating AUG, or near-
cognate codon (Zu et al., 2011). Recently, it was shown that
the expansion of CGG repeats in the 50-UTR of the Fmr1 gene,
which is closely associated with fragile X-associated tremor/
ataxia syndrome (FXTAS), leads to the production of poly-
glycine or polyalanine by RAN translation (Todd et al., 2013),
whose spontaneous aggregation may contribute to the FXTAS
pathologies.
Our understanding of the translation mechanisms comes from
studies using the cell body cytoplasm, and it is possible that
localized translation might employ additional modes of transla-
tional control. New techniques to visualize, isolate and analyze
the translational machinery specifically from different subcellular
compartments will help to address this intriguing possibility.
mRNA-Specific Translation by Extrinsic Cues
Which particular mRNAs are selected for translation determines
how a cell will react to a signal. For example, whereas attractive
guidance cues (e.g., BDNF and netrin-1) stimulate local transla-
tion of the b-actin mRNA in the growth cone (Leung et al., 2006;
Yao et al., 2006), repulsive cues (e.g., Sema3A and Slit2b) induce
local translation of mRNAs encoding proteins that promote actin
disassembly, such as cofilin (Piper et al., 2006) and RhoA (Wu
et al., 2005). The ‘‘differential translation model’’ of growth
cone steering thus predicts that the identity of mRNAs selected
for local translation determines the direction of turning in re-
sponse to extrinsic signals (Lin and Holt, 2007). Such stimulus-
driven mRNA-specific local translation spatiotemporally links
signal reception to gene function, and how this mRNA-specific
translation is regulated is a critical unanswered question.
mRNAs Are Transported and Stored in mRNP Granules
To understand how mRNA-specific translation occurs, it is im-
portant to consider how different mRNAs are transported to spe-
cific subcellular compartments since the pool of resident mRNAs
will limit selection. Directed transport of an mRNA requires en-
gagement of cytoskeletal motors (Figure 3). Cellular mRNAs
are associated with RNA-binding proteins (RBPs), which directly
or indirectly bind to motor proteins in membraneless, high mole-
cular weight messenger ribonucleoprotein (mRNP) granules,
Figure 3. Localized Gene Expression by Translational Control of Localized mRNAs
mRNAs and RNA-binding proteins form heterogeneous mRNP granules, which are transported to subcellular compartments in a translationally repressed state.
Of locally stored mRNAs (local transcriptome), a selected pool of mRNAs is translated (local translatome) depending on the signaling input.which contain mRNAs, proteins and regulatory RNAs. The com-
position of anmRNPdetermines the subcellular localization of its
mRNA components (Erickson and Lykke-Andersen, 2011). One
of the best examples was documented in budding yeast, in
which Puf3, a Pumilio RBP family member, specifically binds to
mRNAs encoding mitochondrial proteins (Gerber et al., 2004),
and transports them to the mitochondria, ensuring that the pro-
teins are made where they will be used (Garcı´a-Rodrı´guez et al.,
2007). Similarly, other Pumilio family members bind to mRNAs
encoding distinct, functionally related proteins, such as compo-
nents of the spindle and nucleolar bodies (Gerber et al., 2004).
It has become clear that many mRNAs are earmarked for spe-
cific compartments from their birth in the nucleus, as all major
nuclear events—transcription, pre-mRNAsplicingandnuclear ex-
port—deposit specific components to an mRNP, which affect its
localization (Erickson and Lykke-Andersen, 2011). In budding
yeast, restricted localization of Ash1mRNAs to the bud tip of the
daughter cell ensures its expression there, and the disruption of
Ash1mRNA interactionwith She2p, anRBP that shuttles between
the nucleus and cytoplasm, specifically in the nucleus results in
diffuse localization of Ash1mRNA throughout the whole bud and
impaired sorting of Ash1 protein (Shen et al., 2009). In addition,
the nuclear pre-mRNA cap-binding complex protein CBP80 is
bound to dendritically localized mRNPs, indicating that dendriti-
cally targeted mRNPs are assembled in the nucleus and trans-
ported in a translationally repressed form (di Penta et al., 2009).mRNP Is a Reversibly Self-Assembling Macromolecular
Complex
Knowledge of the composition of mRNP granules could be rele-
vant to the understanding ofmRNA transport. Processing bodies
(P-bodies) and stress granules are the best understood classes
of mRNP granules. P-bodies contain multiple mRNAs, mRNA
decapping proteins such as Dcp 1 and 2, and translational re-
pressors such as Lsm proteins, which are thought to play a
role in storage and/or degradation of mRNAs, although their ex-
act functions remain unclear. Stress granules, by contrast, con-
tain the small ribosomal subunit, translation initiation factors, the
poly(A)-binding protein (PABP), and the translational repressors
TIA-1 and TIAR, and are thought to play a role in storing mRNAs
whose translation is stalled at the initiation step. The neuronal
RNA granule is an mRNP that transports mRNAs in neurons
and contain distinct RBPs with little overlap with stress granules
or P-bodies (Liu-Yesucevitz et al., 2011). Recent proteomic stud-
ies comparing the composition of two neuronal RNPs, one con-
taining Staufen and the other Barentsz, have shown that neuro-
nal RNA granules are highly heterogeneous and potentially bind
to specific mRNAs (Fritzsche et al., 2013). Although these three
types of mRNP granules—stress granules, P-bodies and neuro-
nal RNA granules—can be distinguished by specific markers,
their function appears to be similar (Erickson and Lykke-
Andersen, 2011). Indeed, submicroscopic mRNPs, transport
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and translating ribosomesmay simply represent different phases
of a dynamic mRNP life cycle.
Intriguingly, many RBPs, such as the P-body component
Lsm4 and the stress granule component TIA-1, contain low-
complexity, prion-like domains, which have a tendency to spon-
taneously assemble into a high molecular weight complex
through parallel alignment of these domains. This self-assem-
bling property may be a universal feature of mRNP granules,
as the domains alone can form an amyloid-like hydrogel in a
cell-free system (Kato et al., 2012). The assembly and disassem-
bly of mRNPs may be regulated, as exemplified by hydrogel for-
mation and reversal by temperature changes (Kato et al., 2012)
and phosphorylation (Han et al., 2012), providing a novel con-
ceptual basis for reversible mRNP formation. mRNA selectivity
of mRNPs appears to be a property of RBPs, as hydrogel formed
from purified low-complexity sequence domains of FUS, an RBP
associated with the pathogenesis of amyotrophic lateral sclero-
sis (ALS), preferentially binds to known mRNA components of
mRNP granules in neurons— mRNAs with long 30-UTRs (Han
et al., 2012).
Different mRNAs are transported and stored together. Live
imaging of fluorescently labeled mRNAs injected into hippocam-
pal neurons in culture revealed that mRNAs whose translation
mediates activity-dependent synaptic plasticity, CaMKII a,
neurogranin, and Arc mRNAs, colocalized to the same mRNP
granules containing the RBP hnRNPA2 in neuronal dendrites
(Gao et al., 2008). While it requires more corroboration (see Per-
spectives and Future Directions), these results suggest that
functionally related mRNAs might be multiplexed for targeting
and storage.
Transported mRNAs Contain cis-Acting Elements and
Are Translationally Inactive
The regulatory elements that control mRNA localization must be
encoded in the mRNA itself, and indeed, the 30-UTR is where
many localization elements lie. The cis-elements can be primary
nucleotide sequences, such as those in the 30-UTRs of b-actin,
RhoA, EphA2, CoxIV, and Impa-1 mRNAs (Andreassi et al.,
2010; Aschrafi et al., 2010; Bassell et al., 1998; Brittis et al.,
2002; Zhang et al., 2001), or secondary structures such as the
hairpins found in the 30-UTR of bicoid mRNA in Drosophila
oocytes (Macdonald and Struhl, 1988) and Ash1 mRNA in the
budding yeast (Chartrand et al., 1999). Cis-elements, however,
can also be localized to the 50-UTRs as in kor mRNA (Tsai
et al., 2007); to the protein-coding sequence as in the target
mRNAs of the RBP fragile X mental retardation protein (FMRP)
(which is encoded by Fmr1 gene) (Ascano et al., 2012; Darnell
et al., 2011) andRobo3mRNA (Kuwako et al., 2010); or to introns
as in some dendritically targeted mRNAs (Buckley et al., 2011).
mRNAs may be localized during translation as the signal peptide
in nascent proteins can target entire translating mRNP com-
plexes (Eliyahu et al., 2010; Kilchert and Spang, 2011).
Targeting of intron-retaining mRNAs to dendrites demonstrate
that they do not undergo nonsense-mediated decay (Behm-
Ansmant et al., 2007). This, together with the findings that the
nuclear capping proteins CBP20/80 and EJC components local-
ize to and are required for the proper localization of cytosolic
mRNPs, suggests that mRNA targeting begins in the nucleus
and that mRNAs are transported to their destination without32 Cell 157, March 27, 2014 ª2014 The Authorsbeing translated (Figure 3). The presence of in-frame stop
codons in the retained introns of dendritically targeted mRNAs
prompted the suggestion of cytoplasmic splicing (Buckley
et al., 2011), a notion (Ko¨nig et al., 2007) that is not universally
supported. While this idea has been strongly challenged (Friend
et al., 2008; Pessa et al., 2008; Singh and Padgett, 2009), splic-
ing activity was also reported in enucleated platelets (Denis et al.,
2005) and dendrites (Glanzer et al., 2005). Local splicing in cyto-
plasmic subcellular compartments to generate transcript var-
iants and regulate gene expression was suggested by Eberwine,
and coined the ‘‘RNA sentinel hypothesis’’ (Buckley et al., 2014),
which is a tantalizing idea that merits further studies.
CombinatorialModularity ofmRNPsGeneratesDiversity
and Specificity
How are thousands of distinct mRNAs targeted to different sub-
cellular locations? Most localization elements bind specific
trans-acting factors such as RBPs. Well-studied examples of
RBPs and their cognate-binding sites include cytoplasmic poly-
adenylation element-binding proteins (CPEBs) that are transla-
tional repressors, recognizing a specific sequence element
CPE (Richter, 1999), and Staufen (Ferrandon et al., 1997) and
FMRP (Darnell et al., 2001) that bind to stem-loop and G-quartet
structures present in their target mRNAs, respectively. Distinct
microRNAs are localized to specific subcellular compartments
(Han et al., 2011; Kaplan et al., 2013; Sasaki et al., 2014), sug-
gesting that they regulate the composition of locally translatable
mRNAs by degrading or silencing their target mRNAs. Localiza-
tion elements exhibit modularity, as they are functional even
when ectopically fused to a reporter mRNA (Eom et al., 2003).
Many mRNAs contain multiple cis-elements exhibiting both re-
dundancy and diversity. For example, bicoid mRNA contains
five redundant stem-loop structures in the 30-UTR, which have
additive effects on the anterior localization of bicoid mRNA in
Drosophila oocytes (Macdonald et al., 1993). CamKIIa mRNA,
which is dendritically localized in mature neurons, contains
several distinct cis-elements including a primary sequence
CPE (Huang et al., 2003) and a secondary structure G-quartet
(Subramanian et al., 2011). This combinatorial modularity of
cis-elements and their binding partners may generate RBP
codes, not unlike the transcriptional code specifying the fate of
the cell bearing them (Briscoe et al., 2000). The RBP code dic-
tates where an mRNP will be localized, as dynamic interaction
of RBPs with different cytoskeletal motor proteins contributes
to the localization of mRNPs (Liu-Yesucevitz et al., 2011) (Fig-
ure 3). Additional diversity may come from tuning RBPs toward
different mRNAs, as the ELAV/HuB RBP binds to different sets
of mRNAs after a progenitor cell differentiates into a neuron
(Tenenbaum et al., 2000).
Stimulus-Specific mRNA Translation
The above features of mRNPs provide a conceptual basis for the
notion of subcellular RNA operons by generating a manageable
diversity of localized mRNAs from which those encoding func-
tionally-related proteins are chosen for translation on demand.
Indeed, synchronous translation of relatedmRNAs occurs during
the immune response (Levine et al., 1993), upon cellular stress
(Gorospe, 2003), in circadian rhythm (Garbarino-Pico et al.,
2007) and during synaptic communication (Zalfa et al., 2003).
The target-derived cue engrailed-1, when added to retinal axons
that were severed from their cell bodies, stimulates translation of
some mRNAs such as lamin B2, but represses that of others
such as hsp70 (Yoon et al., 2012). As previously mentioned,
attractive and repulsive guidance cues induce the translation
of mRNAs encoding proteins promoting actin assembly and dis-
assembly, respectively (Leung et al., 2006; Piper et al., 2006; Wu
et al., 2005; Yao et al., 2006). In dendrites, stimuli that induce
long-term potentiation promote translation of a specific set of
mRNAs that include Arc (activity-regulated cytoskeleton-associ-
ated protein) (Steward et al., 1998), whereas long-term depres-
sion-inducing stimuli promote that of different mRNAs such as
IRSp53 (insulin receptor substrate p53) (McEvoy et al., 2007).
Whether cue-specific cotranslation of related mRNAs results
from the formation of a high-order mRNP granule or simultane-
ous translation of separate mRNP granules remains to be
determined.
Translation and Human Disease
Although mRNA translation plays a vital role in every cell in the
organism, surprisingly, loss-of-function mutations in translation
factors and their regulators often result in defects restricted pre-
dominantly to the nervous system, for example imbalance in ex-
citatory and inhibitory synapses (Geschwind and Levitt, 2007;
Gkogkas et al., 2013). It is plausible that small changes in the
amounts of specific proteins in the dendrites and axons have
much larger effects than in other tissues. As evidence points
increasingly to a key role for local translation in dendrites and
axons in neural wiring and maintenance, it is conceivable that
dysregulated local translation in these distal neuronal compart-
ments may contribute to, and even underlie, the pathophysiol-
ogy in these conditions. This concept, however, has not been
experimentally validated, as it has not yet been technically feasi-
ble to inhibit mRNA translation locally for prolonged time periods
in vivo. However, promising progress in this direction is being
made. Nonphosphorylatable 4E-BP1 was engineered to be pro-
duced by an mRNA with a 30-UTR of b-actin mRNA that targets
the mRNA to axons and dendrites (Eom et al., 2003), and a 50
IRES that permits cap-independent translation (Hellen and Sar-
now, 2001), avoiding translational inhibition by its own gene
product. This mutant form of 4E-BP1 was synthesized in neuro-
nal axons and dendrites, thereby locally exerting its inhibitory
effect on cap-dependent translation (Hsiao et al., 2014). This
approach could provide ameans to address the important ques-
tion whether dysfunctional translation at pre- and postsynaptic
compartments contributes to neurodegenerative and neurode-
velopmental diseases in vivo.
Neurodegenerative Diseases
mRNP Aggregates and ALS. Dramatic progress in human genet-
ics has revealed a striking link between RBPs and human neuro-
degenerative disease. For example, mutations in the RBPs,
hnRNPA1 and A2B1 (Kim et al., 2013), TDP-43 (Sreedharan
et al., 2008), and FUS (Kwiatkowski et al., 2009; Vance et al.,
2009) are strongly associated with ALS. These RBPs possess
prion-like domains with self-assembling properties (as de-
scribed above), and intriguingly are found in unusually large ag-
gregates in diseased cells. The finding that the self-assembly
ability of these proteins is enhanced by mutations found in ALS
patients is very exciting (Kim et al., 2013). Under physiologicalconditions, many mRNP granules containing these RBPs shuttle
between the nucleus and the cytoplasm where they disperse, so
that the precise location where the pathological RBPs cause
damages to the cell is unknown (Ramaswami et al., 2013). It is
likely, however, that these pathological aggregates irreversibly
trap physiological submicroscopic mRNP granules, preventing
them from being transported to appropriate subcellular com-
partments including distal axons. As there is evidence that sus-
tained local translation in distal axons is key to neuronal survival
(Jung et al., 2012; Kaplan et al., 2009), it is plausible that de-
creased translation of mRNAs trapped in pathological aggre-
gates might damage distal axons and that the accumulation of
such damage causes the death of postmitotic neurons. The
upper and lower motor neurons, which are among those that
have the longest axons and are prone to degeneration in ALS
patients, might be particularly sensitive to pathological mRNP
aggregates asmRNP transport may impact themmore than neu-
rons with shorter axons.
eIF2a and Prion Diseases. Decreased global translational ac-
tivity is observed in a wide range of neurodegenerative diseases,
such as Alzheimer’s, Parkinson’s and prion diseases (Hooze-
mans et al., 2012; Moreno et al., 2012). In prion-infected mice,
which are a model of prion disease, the accumulation of mis-
folded proteins activates PERK, which represses global transla-
tional activity by phosphorylating eIF2a (Moreno et al., 2012)
(Figure 2A). Remarkably, decreasing eIF2a phosphorylation in
neurons almost completely rescues the failure of synaptic trans-
mission and the death of neurons in these mice, indicating that
the repression of global translational activity causes the pathol-
ogy (Moreno et al., 2012). Intriguingly, a sudden decline in the
level of synaptic proteins precedes defective synaptic function
and neuronal loss during pathogenesis, suggesting that defec-
tive maintenance of the synaptic proteome might be an underly-
ing cause of neurodegeneration.
Considering the evidence that local mRNA translation is re-
quired for presynaptic maturation (Taylor et al., 2013) and plasti-
city (Zhang and Poo, 2002), it is likely that sustained local
translation in the presynaptic terminal is required for synaptic
maintenance in adult mice. In support of this notion is the finding
that translational activity is enhanced by extrinsic cues that
axons encounter in vivo (such as BDNF, netrins and semaphor-
ins), either by increasing 4E-BP phosphorylation via the activa-
tion of mTORC1 (Campbell and Holt, 2001) or by decreasing
eIF2a phosphorylation potentially through inhibition of either
PERK or GCN2, or activation of eIF2a phosphatases (Nukazuka
et al., 2008). It will be important to determine whether the sus-
tained repression in presynaptic mRNA translation, as opposed
to global translational, contributes to neuronal loss in neurode-
generative diseases.
Neurodevelopmental Diseases
Fragile X Syndrome: The Loss of a Translational Brake. FMRP is a
negative regulator of translation, which binds to the coding
sequences of polysome-bound mRNAs and stalls the elongating
ribosomes (Darnell et al., 2011). Mutations in the human FMRP-
coding gene (Fmr1) are associated with neurodevelopmental
disorders, such as fragile Xmental retardation, a disease charac-
terized by intellectual disability, disruptive and autistic-like be-
havior, epileptic seizures and language deficits (Darnell andCell 157, March 27, 2014 ª2014 The Authors 33
Klann, 2013), and autism (Zukin et al., 2009). In the developing
mouse brain, FMRP-containing granules localize to dendrites
and axons (Christie et al., 2009), and the loss of FMRP function
leads to defective formation of pre- and postsynaptic terminals
(Darnell and Klann, 2013). These studies suggest that excessive
translation due to the loss of a translational brake (FMRP) results
in the development of aberrant neuronal connections and the be-
havioral manifestations of fragile X syndrome in adulthood.
mTORC1 Hyperactivation and Neurodevelopmental Disor-
ders. Mutations in other negative regulators of translation have
also been implicated in neurodevelopmental disorders. Autism
spectrum disorders (ASDs) encompass a wide spectrum of neu-
rodevelopmental diseases characterized by impaired cognition
and communication (Geschwind and Levitt, 2007). ASDs are
associated with mutations that lead to hyperactivation of the
mTORC1 pathway (Kelleher and Bear, 2008). In tuberous sclero-
sis, which results frommutations in the mTORC1-negative regu-
lators Tsc1 or Tsc2, 85% of affected patients display cognitive
impairment tightly linked to autistic features, epilepsy and abnor-
mal or absent speech (Curatolo et al., 2008). Similarly, mutations
in the mTORC1-negative regulator Pten lead to PTEN hamar-
toma syndrome, which manifests with neurobehavioral features
resembling autism, macrocephaly and language impairment
(Zhou and Parada, 2012). Down syndrome, the most common
chromosomal abnormality (trisomy of chromosome 21) leading
to mental retardation, is also associated with hyperactive
mTORC1, and in a mouse model of Down syndrome, hippocam-
pal dendritic translation is increased and can be restored to the
basal level by rapamycin treatment (Troca-Marı´n et al., 2012).
In summary, it has become clear that aberrant fluctuations,
both decreases and increases, in translational activity lead to
pathologies—the former generally causing neurodegenerative
diseases and the latter causing neurodevelopmental diseases,
underscoring the notion that balanced mRNA translation is re-
quired for normal brain development and function. Despite this
association, it is not yet certain whether the etiology of these syn-
dromes lies in the alteration in the global translational activity or
local translation at the synapse. The key to understanding the
pathophysiology of these syndromes will require the elucidation
of the exact location of defective translation, the mechanisms of
aberrant translation, and the target mRNAs whose translation is
altered.
Perspectives and Future Directions
Local Translation at Single-Molecule Resolution
Genome-wide subcellular transcriptome studies revealed that
hundreds and perhaps thousands of different mRNAs localize
to axonal growth cones (Deglincerti and Jaffrey, 2012) and den-
drites (dendritic spines, where activity-dependent translation
occurs) (Cajigas et al., 2012). Although these studies analyzed
mRNAs isolated from a population of neurons, not from a single
neuron, these results do suggest that many mRNA molecules
might coexist in the same axons and dendrites. How can so
manymRNAs be accommodated in these small subcellular com-
partments? Although previous studies have suggested that mul-
tiple mRNAs may be stored in the same mRNP granules (Gao
et al., 2008), recently developed single-RNA-molecule imaging
techniques revealed, unexpectedly, that even mRNAs contain-34 Cell 157, March 27, 2014 ª2014 The Authorsing the same class of cis-element do not colocalize, but travel in-
dividually (Amrute-Nayak and Bullock, 2012; Batish et al., 2012;
Mikl et al., 2011). Quantitative analysis showed that each granule
contained only one or twomRNAmolecules (Mikl et al., 2011). In-
triguingly, the mRNA content of individual granules could be
regulated, up or down, by neuronal activity and the amount of
RBPs (Staufen in this case). This regulation was message-spe-
cific (Map2 but not b-actin mRNA was regulated) (Mikl et al.,
2011). An extensive analysis of single b-actin mRNA molecules
in neuronal dendrites showed that proteinaceous components
of the mRNP granule mask individual mRNAs and ribosomes
making them inaccessible to translational machinery, and that
neuronal activity-dependent ‘‘unmasking’’ may be the molecular
basis of localized translation (Buxbaum et al., 2014).
These new findings suggest that there is a mechanism to keep
mRNP granules physically separate from one another, possibly
by inhibiting their intrinsic self-assembling activity through the
prion-like domain, and that these mRNPs could form higher-
order granules when required (Erickson and Lykke-Andersen,
2011). Evidence that this might be the case in vivo was recently
provided by Singer’s laboratory. Using live tissue from a trans-
genic mouse in which endogenous b-actin mRNAs are bound
to multiple copies of green fluorescent proteins (up to 48 copies
per mRNA), they showed that single b-actin mRNA molecules
undergo continuous assembly and disassembly, and that indi-
vidual mRNA molecules are released from high-order granules
in a neuronal activity-dependentmanner, perhaps for local trans-
lation (Park et al., 2014). Considering that neuronal dendrites
contain hundreds, even thousands of different mRNAs (Cajigas
et al., 2012), there could be numerous mRNPs within these small
neuronal subcellular compartments, which can be regulated in-
dividually. Mutations in RBP-coding genes, such as hnRNPA2
that is associated with neurodegenerative diseases (Kim et al.,
2013), might cause mRNP granules to overly self-assemble to
a degree that cannot be reversed by normal regulatory mecha-
nisms, causing the cell to lose its ability to control local gene
function. New insights into the molecular basis of such diversity
and the mechanism of mRNP-specific assembly/disassembly at
the single-molecule level awaits the invention of new technolo-
gies that will allow us to investigate protein composition of single
mRNP granules. Combining such techniques with fluorescent
in situ RNA sequencing (FISSEQ) (Lee et al., 2014), which visual-
izes thousands of different RNA molecules within a cell in situ, is
an exciting avenue that will lead to the molecular dissection of
individual mRNP granules. These results provide a tantalizing in-
tersection of twomajor themes from the issue as insight into why
LocationMattersmay ultimately emerge from studies harnessing
The Power of One—analysis of single mRNAs and mRNPs.
Coordinated Protein Synthesis and Degradation
Thousands of different mRNPs will make neuronal growth cones
and dendritic spines heavily crowded, indicating that there must
be a mechanism that ensures subcellular proteomic homeosta-
sis is maintained. In line with this idea, molecular machines
that degrade specific proteins, including the ubiquitin protea-
some system (Campbell and Holt, 2001; Chapman et al., 1994;
Ehlers, 2003; Patrick et al., 2003; Speese et al., 2003; Zhao
et al., 2003) and autophagy machinery (Yang et al., 2013), oper-
ate in neuronal axons and dendrites. A surprising findingwas that
local translation-dependent responses, such as cue-induced
growth cone steering and axon regeneration, also require protein
degradation, indicating that protein synthesis and degradation
are closely linked in signal transduction (Campbell and Holt,
2001; Verma et al., 2005). How these seemingly opposite pro-
cesses cooperate to mediate the same response remains a puz-
zle. One possibility is that a spatially restricted, transient rise in
the concentration of a protein is key to translating an extrinsic
signal into a precise signal within the cell. The growth cone’s abil-
ity to steer toward netrin-1 is blocked either by protein synthesis
inhibitors or degradation inhibitors (Campbell and Holt, 2001).
Newly made b-actin molecules in the side near the gradient
source might then have to be degraded before they diffuse
throughout the small space within the growth cone, thus confin-
ing a rise in the b-actin concentration to the site of actin assembly
where it is needed. Alternatively, protein degradation might keep
proteins at the minimum level so that a small rise in protein con-
centration by local translation could generate a meaningful sig-
nal. As it was proposed that cue-induced synthesis of proteins
with short half-lives, which never reach a steady-state level, is
essential in keeping cells responsive to that stimulus (Schwan-
ha¨usser et al., 2011), it would be intriguing to see whether
proteins newly synthesized in the neuronal subcellular compart-
ments are specifically targeted for degradation after their cue-
induced synthesis.
Linking Extrinsic Cues to mRNA Specificity
Howextrinsic cues are linked to the translation of a specific set of
mRNAs is an important question. At least one study directly
addressed this question. Flanagan and colleagues showed that
deleted in colorectal cancer-1 (DCC1), a single transmembrane
cell-surface receptor for netrin-1, directly binds to ribosomes
and translation initiation factors, and translation is promoted by
ligand binding (Tcherkezian et al., 2010). As ribosomes and initia-
tion factors are components of mRNPs such as stress granules
(Erickson and Lykke-Andersen, 2011), their interaction with cell-
surface receptors, which can be regulated by ligand-receptor
interaction, provides a conceptually appealing mechanism of
cue-mRNA specificity. mRNPs containing mRNAs encoding
functionally related proteins could be predocked to a specific
signal-receiving component, such as cell-surface receptors or
adaptor proteins, to allow the swift translation of subcellularly
targeted mRNAs in the vicinity of signal reception by bypassing
the rate-limiting initiation step.
Another intriguing possibility is intracellular ribosome hetero-
geneity. It has become clear that the ribosome shows variable
compositions and mRNA specificity in organisms ranging from
bacteria (Byrgazov et al., 2013) to mammals (Kondrashov et al.,
2011). The ribosome filter hypothesis (Mauro and Edelman,
2002) states that the composition of the ribosome determines
mRNA-selective translation, and continues to be supported
by new pieces of evidence, including ribosomal protein L38
tuning the ribosome toward the Hox mRNAs (Kondrashov
et al., 2011) and ribosomal proteins S6 and S7 tuning the ribo-
some toward intron-containing pre-mRNAs (Apcher et al.,
2013). It is a tantalizing idea that ribosomes bound to a specific
set of mRNAs could be targeted to different subcellular com-
partments waiting for the right moment to start making specific
proteins.Horizontal RNA Transfer
A challenge in regulating gene expression by localized transla-
tion in a compartment distant from the nucleus is the long-
distance mRNAs must travel. For example, injured axons may
need to quickly synthesize a protein, which is not normally
needed and thus whose mRNA is not locally stored. Conceptu-
ally, this could be overcome if mRNAs could be transferred
from a juxtaposed cell. It may be less efficient to transport
mRNAs from the cell body to the tip of the axon than to receive
them from neighboring cells, such as postsynaptic neurons or
perisynaptic glia, and indeed this mechanism has been pro-
posed (Alvarez, 2001).What was a rather provocative hypothesis
initially has gained a solid basis because feedingC. elegans bac-
teria harboring small interfering RNAs (siRNAs), 20–24-nucleo-
tide dsRNAs that posttranscriptionally silence gene expression
in a sequence-specific manner (Fire et al., 1998), leads to gene
silencing in the entire animal, indicating the presence of a mech-
anism for cell-to-cell RNA transfer (Timmons and Fire, 1998).
Furthermore, animals and plants can accept small RNAs from
other organisms both in the same and different species and
even from the environment (Baulcombe, 2013; Sarkies and
Miska, 2013).
Indeed, recent evidence suggests that a similar mechanism
might be used to regulate local mRNA repertoires, as the poly-
some, multiple ribosomes translating a single mRNA, from
Schwann cells can be transferred to the segment of an axon
that they insulate, a process promoted by axonal injury (Court
et al., 2008; Court et al., 2011; Sotelo et al., 2014). Therefore, it
is possible that remote subcellular compartments such as neuro-
nal axons may dynamically regulate the composition of locally
stored mRNAs by horizontal transfer of mRNP granules depend-
ing on extrinsic signals, and this intriguing mechanism may
provide an unmatchable agility and flexibility in dynamically reg-
ulating local gene function. As it has been shown that cells,
notably those in the immune system, use exosomes, secreted
vesicles of endocytic origin, to transfer mRNAs to other cells,
where they can be translated (Valadi et al., 2007), it will be intri-
guing to find out whether exosome-mediated horizontal RNA
transfer is used to regulate the local transcriptome in neurons.
Human Diseases
Advances in sequencing technologies led to the discovery of
new biomarkers and risk genes associated with human
disease. The main focus of human genetic studies is to link
mutations in protein-coding regions, which cause alterations
in protein structure and expression, to diseases. Considering
that localized translation plays a key role in regulating gene
expression and function, mutations in the UTRs that may affect
RNA localization and translation should be another focus that
merits extensive investigation. For this kind of analysis, it will
be essential to systematically categorize and identify mRNA
motifs and sequences important for subcellular targeting and
translational control. Bioinformatic analysis of subcellularly
targeted and/or translating mRNAs will provide a basis for
identifying key cis-elements and subsequently for designing
new therapies to manipulate local translation of specific
mRNAs. This avenue may yield novel therapeutic strategies
for neurodevelopmental and neurodegenerative diseases (as
described above).Cell 157, March 27, 2014 ª2014 The Authors 35
Given the strong evidence linking mRNP granules and neuro-
degenerative diseases, unraveling molecular mechanisms that
regulate mRNP granule assembly, disassembly, and clearance
will shed fresh light into their pathophysiology. Of equal impor-
tance is the distinction between pathological and normal
mRNP granules. A deep understanding of mRNP granules may
point to a new direction in treating neurodegenerative diseases,
by preventing the formation of pathological mRNP aggregates or
facilitating their clearance.
MeasuringmRNA abundance in diseased cells is another main
focus of biomarker discovery. Considering that the abundance
of a protein has a stronger correlation with the translational
rate of itsmRNA thanwith themRNA abundance, it will be critical
to analyze translating mRNAs (translatome) rather than total
mRNAs (transcriptome). Recent genome-wide translational
profiling techniques such as ribosome profiling (Ingolia et al.,
2009) and immunoprecipitation of activated ribosomes and
associated mRNAs (Knight et al., 2012) provide opportunities
to reveal mRNAs whose dysregulated translation is associated
with disease status. Furthermore, a strong implication of local
translation in neurodevelopmental and neurodegenerative dis-
eases indicates that a deeper look into the local translatome in
the axon and dendrite may uncover novel mRNAs whose defec-
tive local translation caused the pathology. Applying transla-
tional profiling strategies to target axons and dendrites in vivo
will be a technical challenge, but overcoming this hurdle may
shed new light into the links between localized translation and
human diseases.Conclusions
Although our appreciation of localized translation is most
advanced in neurons, these examples may just represent the
tip of the iceberg with a resounding message that Location
Matters for control of protein expression. Given the close ties
with neurodevelopment and neurological disease, insights into
how Location Matters will ultimately impact research striving to
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